Vir Biotechnology, Inc.

NasdaqGS:VIR Stock Report

Market Cap: US$1.0b

Vir Biotechnology Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqGS:VIR Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
11 Jun 24SellUS$43,789Sona RamasastryIndividual4,000US$10.95
03 Apr 24SellUS$690,365Marianne De BackerIndividual72,995US$9.46
01 Apr 24SellUS$27,251Ann HanlyIndividual2,711US$10.05
27 Mar 24SellUS$59,404Sung LeeIndividual6,008US$9.89
22 Feb 24SellUS$100,737George ScangosIndividual10,028US$10.05
22 Feb 24SellUS$146,344Phillip PangIndividual14,568US$10.05
22 Feb 24SellUS$123,521Ann HanlyIndividual12,296US$10.05
16 Feb 24SellUS$34,006Phillip PangIndividual3,321US$10.24
16 Feb 24SellUS$111,386George ScangosIndividual10,878US$10.24

Insider Trading Volume

Insider Buying: VIR insiders have only sold shares in the past 3 months.


Ownership Breakdown

What is the ownership structure of VIR?
Owner TypeNumber of SharesOwnership Percentage
Private Companies10,0000.00732%
State or Government39,6480.029%
Individual Insiders6,923,2095.07%
Public Companies8,550,9546.26%
General Public19,168,23914%
VC/PE Firms29,600,70421.7%
Institutions72,346,81752.9%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 25 shareholders own 73.87% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
12.2%
SB Investment Advisers (UK) Limited
16,684,041US$126.8m0%0.76%
12%
BlackRock, Inc.
16,434,122US$124.9m-0.78%no data
9.45%
Arch Venture Partners, L.P.
12,916,663US$98.2m0%8.55%
9.4%
The Vanguard Group, Inc.
12,849,217US$97.7m3.83%no data
6.26%
GSK plc
8,550,954US$65.0m0%no data
3.73%
State Street Global Advisors, Inc.
5,094,888US$38.7m-27.9%no data
2.87%
Baillie Gifford & Co.
3,921,242US$29.8m-0.65%0.01%
2.8%
George Scangos
3,826,548US$29.1m2.99%no data
1.7%
OrbiMed Advisors LLC
2,320,102US$17.6m263%0.27%
1.6%
Geode Capital Management, LLC
2,183,628US$16.6m12%no data
1.14%
Bill & Melinda Gates Foundation Trust
1,559,142US$11.8m0%0.03%
1.08%
Morgan Stanley, Investment Banking and Brokerage Investments
1,475,280US$11.2m0.13%no data
0.97%
Renaissance Technologies LLC
1,329,700US$10.1m-1.95%0.02%
0.97%
Vicki Sato
1,323,351US$10.1m0.61%no data
0.94%
Bridgeway Capital Management, LLC
1,282,208US$9.7m-25.8%0.17%
0.91%
Millennium Management LLC
1,248,131US$9.5m94.6%0.01%
0.9%
Voloridge Investment Management, LLC
1,224,898US$9.3m74.1%0.04%
0.73%
Charles Schwab Investment Management, Inc.
998,189US$7.6m20.4%no data
0.68%
JP Morgan Asset Management
925,480US$7.0m185%no data
0.68%
D. E. Shaw & Co., L.P.
922,554US$7.0m42.8%0.01%
0.61%
Northern Trust Global Investments
833,491US$6.3m-2.92%no data
0.6%
Bank of America Corporation, Asset Management Arm
818,272US$6.2m-25.9%no data
0.6%
BNY Asset Management
813,288US$6.2m0.79%no data
0.55%
Citadel Advisors LLC
749,987US$5.7m-78%0.01%
0.47%
Eaton Vance Management
646,065US$4.9m-25.3%no data